NASDAQ·US·Drug Manufacturers - General

LLYLLY

สรุป

ปานกลาง

ความมั่นใจ 89%
$851.21—

Today's session

Upside?
-5.5%
FV $804.12
P/E (TTM)?
37.0
Earnings yield
FCF yield?
0.3%
Mcap $760.43B

ถือ

Fundamental neutral·Technical sell

What investors notice

Key signs

Plain-language read of the metrics that matter most for this stock.

Strongly positive
8 · 1 · 1

Strengths

8
  • Best-in-class return on equity65%
  • High return on invested capital30%
  • Gross margin trending up
  • EPS compounding at double-digit pace52%
  • Recent growth re-accelerating
  • Pristine fundamentals (Piotroski 7+)7/9
  • ROIC well above cost of capital — value-creating30%
  • Analyst consensus heavily Buy-skewed

Risks

1
  • Inconsistent profitability4/10

Watchlist

1
  • Long-term debt rising — monitor leverage
$851.21-3.1%

1Y · period change vs 2025-04-29

Score history (10y)

How quality has trended through cycles.

+2 YoY

Verdict bands: 85+ Wonderful · 70 Solid · 55 Average · 40 Risky.

Fair value range

3 of 5 models · trimmed-mean consensus

Consensus FV
$804.12
Upside
-5.5%
Now $851.21
Our FV$804.12
Price$851.21
$0.00$1,265.38

Open the Fair Value tab to tweak WACC and growth, and to see all five model outputs side-by-side.

10-year financials

Annual revenue, profit, and free cash flow with year-over-year growth overlay.

YoY growth overlaid

Snapshot

At a glance

Top-line figures most investors check first.

Market cap
$760.43B
P/E (TTM)?
37.0
FCF yield?
0.3%
Dividend
$6.00
0.7% yield
52w range
$622.32 – $1,108.09
Score confidence
89%
Data completeness

Last updated 4/30/2026, 4:19:09 AM · Data via Yahoo Finance, FMP, EDGAR. Disclaimer